{"title":"Withholding of Life-Sustaining Treatment and Mortality in ICU Patients with Severe Acute COPD Exacerbations: A Retrospective French Cohort.","authors":"Pauline Puechoultres, Matthieu Jamme, Georges Abi-Abdallah, Sylvain Diop, Stéphane Legriel, Alexis Ferré","doi":"10.2147/COPD.S502019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Data on withholding life-support (WLS) decisions during acute exacerbations of chronic obstructive pulmonary disease (COPD) in the intensive care unit (ICU) are scarce. This study aimed to identify factors associated with these decisions and their impact on mortality.</p><p><strong>Methods: </strong>We conducted a monocentric retrospective cohort study on all patients admitted to our ICU between 2015 and 2021 for a severe acute exacerbation of COPD. Logistic multivariable regression analysis was performed.</p><p><strong>Results: </strong>We included 463 patients of whom 128 (27.6%) had a decision of withholding of care. The 3-months mortality was 49.2% and 4.8% in the WLS group and in the no WLS group, respectively. Forty-eight patients (10.4%) had advanced healthcare directives. In multivariable analysis, factors associated with a decision of WLS were higher age (odds ratio [+10 years] = 1.93, <i>p</i> < 0.001), immunodeficiency (OR = 3.07, <i>p</i> < 0.001), higher Performance Status (PS) score (OR [+1 point] = 2.10, <i>p</i> < 0.001), long-term oxygen therapy (OR = 4.11, <i>p</i> < 0.001) and shock after ICU admission (OR = 2.43, <i>p</i> = 0.01). In multivariate analysis, factors significantly associated with 3-month mortality included decision of WLS during ICU (OR = 22.98, <i>p</i> < 0.001) and invasive mechanical ventilation (OR = 2.72, p < 0.001).</p><p><strong>Conclusion: </strong>Approximately 30% of COPD patients underwent a decision to withhold life-sustaining treatment. Higher age, immunosuppression, increased PS score, and long-term oxygen therapy were significantly associated with this decision. Nearly half of the patients died within three months following a withholding of care decision.</p>","PeriodicalId":48818,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":"20 ","pages":"1995-2009"},"PeriodicalIF":2.7000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12183566/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/COPD.S502019","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
摘要
背景:在重症监护病房(ICU)慢性阻塞性肺疾病(COPD)急性加重期间,保留生命支持(WLS)决定的数据很少。本研究旨在确定与这些决定相关的因素及其对死亡率的影响。方法:我们进行了一项单中心回顾性队列研究,纳入了2015年至2021年间因COPD严重急性加重而入住我们ICU的所有患者。进行Logistic多变量回归分析。结果:我们纳入了463例患者,其中128例(27.6%)决定放弃治疗。WLS组和无WLS组3个月死亡率分别为49.2%和4.8%。48名患者(10.4%)有先进的医疗保健指示。在多变量分析中,与WLS决定相关的因素为年龄较大(优势比[+10年]= 1.93,p < 0.001)、免疫缺陷(OR = 3.07, p < 0.001)、性能状态(Performance Status, PS)评分较高(OR[+1分]= 2.10,p < 0.001)、长期氧疗(OR = 4.11, p < 0.001)和ICU入院后休克(OR = 2.43, p = 0.01)。在多因素分析中,与3个月死亡率显著相关的因素包括ICU期间WLS的判定(OR = 22.98, p < 0.001)和有创机械通气(OR = 2.72, p < 0.001)。结论:大约30%的COPD患者决定停止生命维持治疗。较高的年龄、免疫抑制、PS评分升高和长期氧疗与这一决定显著相关。将近一半的病人在拒绝护理决定后的三个月内死亡。
Withholding of Life-Sustaining Treatment and Mortality in ICU Patients with Severe Acute COPD Exacerbations: A Retrospective French Cohort.
Background: Data on withholding life-support (WLS) decisions during acute exacerbations of chronic obstructive pulmonary disease (COPD) in the intensive care unit (ICU) are scarce. This study aimed to identify factors associated with these decisions and their impact on mortality.
Methods: We conducted a monocentric retrospective cohort study on all patients admitted to our ICU between 2015 and 2021 for a severe acute exacerbation of COPD. Logistic multivariable regression analysis was performed.
Results: We included 463 patients of whom 128 (27.6%) had a decision of withholding of care. The 3-months mortality was 49.2% and 4.8% in the WLS group and in the no WLS group, respectively. Forty-eight patients (10.4%) had advanced healthcare directives. In multivariable analysis, factors associated with a decision of WLS were higher age (odds ratio [+10 years] = 1.93, p < 0.001), immunodeficiency (OR = 3.07, p < 0.001), higher Performance Status (PS) score (OR [+1 point] = 2.10, p < 0.001), long-term oxygen therapy (OR = 4.11, p < 0.001) and shock after ICU admission (OR = 2.43, p = 0.01). In multivariate analysis, factors significantly associated with 3-month mortality included decision of WLS during ICU (OR = 22.98, p < 0.001) and invasive mechanical ventilation (OR = 2.72, p < 0.001).
Conclusion: Approximately 30% of COPD patients underwent a decision to withhold life-sustaining treatment. Higher age, immunosuppression, increased PS score, and long-term oxygen therapy were significantly associated with this decision. Nearly half of the patients died within three months following a withholding of care decision.
期刊介绍:
An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals